Custom Truck One Source, Inc. (CTOS) earnings date, results and what the price requires
NYSE · SEC CIK 0001709682 · SEC filings checked Oct 18, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 3, 2026 | $417.6M | $10.4M | $0.05 | Filing |
| Mar 31, 2026 | Apr 27, 2026 | $328.6M | $-4.1M | $-0.02 | Filing |
| Dec 31, 2025 | Mar 10, 2026 | $387.3M | $20.8M | $0.10 | Filing |
| Sep 30, 2025 | Oct 27, 2025 | $359.9M | $-5.8M | $-0.03 | Filing |
| Jun 30, 2025 | Jul 30, 2025 | $392.2M | $-28.4M | $-0.13 | Filing |
| Mar 31, 2025 | Apr 30, 2025 | $307.1M | $-17.8M | $-0.08 | Filing |
| Dec 31, 2024 | Mar 4, 2025 | $398.3M | $27.5M | $0.11 | Filing |
| Sep 30, 2024 | Oct 30, 2024 | $337.5M | $-17.4M | $-0.07 | Filing |
What would Custom Truck One Source, Inc. have to report for its valuation to change?
At $9.08, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 50.7% a year, to $0.78. On that path the next quarter needs diluted EPS near $-0.05, against $-0.03 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 50.7% | 50.7% |
| EPS needed in final year | $0.78 | $0.78 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. CTOS goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.